ATEX Stock Analysis: Anterix | NASDAQ
Telecom Services | NASDAQ, USA | Market Cap: 1.496m USD | 12M Return: 316.7% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 44.5M
Qual. Beats: 0
Rev. Trend: 88.2%
Qual. Beats: 1
Warnings
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Anterix Inc. (NASDAQ: ATEX) is a wireless communications company that commercializes spectrum assets to support private broadband networks for utilities and other critical infrastructure operators. The company monetizes its 900 MHz spectrum holdings-covering the contiguous United States, Hawaii, Alaska, and Puerto Rico-primarily by leasing spectrum rights that allow customers to deploy their own dedicated LTE networks instead of relying on commercial carrier services.
The companys product portfolio includes the CatalyX ecosystem platform, complementary spectrum offerings, the Anterix Security Collective, and rural broadband services. The 900 MHz band is particularly well-suited for utility-grade private networks because lower-frequency signals propagate over long distances and through dense vegetation or structures, enabling wide-area coverage with fewer cell sites.
Anterix was incorporated in 1997 and is headquartered in Woodland Park, New Jersey. The company previously operated as pdvWireless before adopting its current name in August 2019, and it trades as a small-cap stock within the Communication Services sector under the Wireless Telecommunication Services sub-industry.
- Major utility customers sign 900 MHz private LTE contracts
- FCC 900 MHz band clearing completion unlocks spectrum monetization timeline
- Negative operating cash flow intensifies capital structure and dilution risk
| Net Income: 90.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA 13.27 > 1.0 |
| NWC/Revenue: 1.29k% < 20% (prev 556.4%; Δ 735.6% < -1%) |
| CFO/TA 0.01 > 3% & CFO 5.51m > Net Income 90.6m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 3.33 > 1.5 & < 3 |
| Outstanding Shares: last quarter (18.9m) vs 12m ago 0.82% < -2% |
| Gross Margin: 92.86% > 18% (prev 100.0%; Δ -7.14% > 0.5%) |
| Asset Turnover: 1.63% > 50% (prev 1.81%; Δ -0.18% > 0%) |
| Interest Coverage Ratio: error (cannot be calculated; needs correct EBIT TTM and Interest Expense TTM) |
| A: 0.18 (Total Current Assets 120.0m - Total Current Liabilities 36.0m) / Total Assets 465.2m |
| B: -0.65 (Retained Earnings -302.3m / Total Assets 465.2m) |
| C: -0.03 (EBIT TTM -10.9m / Avg Total Assets 399.2m) |
| D: 1.29 (Book Value of Equity 262.3m / Total Liabilities 202.9m) |
| Altman-Z'' = 0.24 = B |
| DSRI: 0.98 (Receivables 10.6m/10.0m, Revenue 6.50m/6.03m) |
| GMI: 1.08 (GM 100.0% / 92.86%) |
| AQI: 0.92 (AQ_t 0.73 / AQ_t-1 0.80) |
| SGI: 1.08 (Revenue 6.50m / 6.03m) |
| TATA: 0.18 (NI 90.6m - CFO 5.51m) / TA 465.2m) |
| Beneish M = -2.94 (Cap -4..+1) = A |
As of July 04, 2026, the stock is trading at USD 105.14 with a total of 612,157 shares traded. Over the past week, the price has changed by +29.80%, over one month by +57.11%, over three months by +160.44% and over the past year by +316.73%.
Current recommended Stop Loss: 97.70 (which is 7.1% or 1.2 ATR below the current price).
Anterix has received a consensus analysts rating of 4.67. Therefore, it is recommended to buy ATEX.
- StrongBuy: 2
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 80 | -23.9% |
P/E Trailing = 16.3747
P/S = 230.1076
P/B = 5.7668
Revenue TTM = 6.50m USD
EBIT TTM = -10.9m USD
EBITDA TTM = -10.4m USD
Long Term Debt = 3.00m USD (estimated: total debt 4.42m - short term 1.42m)
Short Term Debt = 1.42m USD (from shortTermDebt, last quarter)
Debt = 9.06m USD (from shortLongTermDebtTotal, last quarter) + Leases 4.64m
Net Debt = -89.5m USD (calculated: Debt 9.06m - CCE 98.5m)
Enterprise Value = 1.41b USD (1.50b + Debt 9.06m - CCE 98.5m)
Interest Coverage Ratio = unknown (Ebit TTM -10.9m / Interest Expense TTM 0.0)
EV/FCF = 256.7x (Enterprise Value 1.41b / FCF TTM 5.48m)
FCF Yield = 0.39% (FCF TTM 5.48m / Enterprise Value 1.41b)
FCF Margin = 84.29% (FCF TTM 5.48m / Revenue TTM 6.50m)
Net Margin = 1.39k% (Net Income TTM 90.6m / Revenue TTM 6.50m)
Gross Margin = 92.86% ((Revenue TTM 6.50m - Cost of Revenue TTM 464k) / Revenue TTM)
Gross Margin QoQ = none% (prev none%)
Tobins Q-Ratio = 3.02 (Enterprise Value 1.41b / Total Assets 465.2m)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt 9.06m)
Taxrate = 5.30% (5.07m / 95.7m)
NOPAT = -10.3m (EBIT -10.9m * (1 - 5.30%)) [loss with tax shield]
Current Ratio = 3.33 (Total Current Assets 120.0m / Total Current Liabilities 36.0m)
Debt / Equity = 0.03 (Debt 9.06m / totalStockholderEquity, last quarter 262.3m)
Debt / EBITDA = 8.61 (negative EBITDA) (Net Debt -89.5m / EBITDA -10.4m)
Debt / FCF = -16.33 (Net Debt -89.5m / FCF TTM 5.48m)
Total Stockholder Equity = 230.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 22.71% (Net Income 90.6m / Total Assets 465.2m)
RoE = 39.26% (Net Income TTM 90.6m / Total Stockholder Equity 230.8m)
RoCE = -4.64% (EBIT -10.9m / Capital Employed (Equity 230.8m + L.T.Debt 3.00m))
RoIC = -2.39% (negative operating profit) (NOPAT -10.3m / Invested Capital 430.3m)
WACC = 9.38% (E(1.50b)/V(1.50b) * Re(9.44%) + D(9.06m)/V(1.50b) * Rd(0.0%) * (1-Tc(0.05)))
Discount Rate = 9.44% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 20.0 | Cagr: -0.13%
[DCF] Terminal Value 71.89% ; FCFF base≈5.48m ; Y1≈5.50m ; Y5≈5.83m
[DCF] Fair Price = 8.81 (EV 77.1m - Net Debt -89.5m = Equity 166.6m / Shares 18.9m; r=9.38% [WACC]; 5y FCF grow 0.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.12 | # QB: 0
Revenue Correlation: 88.17 | Revenue CAGR: 40.78% | SUE: 2.45 | # QB: 1
EPS current Quarter (2026-09-30): EPS=0.18 | Chg30d=+176.60% | Revisions=N/A | Analysts=2
EPS current Year (2027-03-31): EPS=-1.33 | Chg30d=+0.00% | Revisions=+20% | GrowthEPS=-127.5% | GrowthRev=+1.5%
EPS next Year (2028-03-31): EPS=4.51 | Chg30d=N/A | Revisions=N/A | GrowthEPS=-6.6% | GrowthRev=+33.7%
[Analyst] Revisions Ratio: +20%